Improved outcome of high-risk early HER2 positive breast cancer with high CXCL13-CXCR5 messenger RNA expression.
暂无分享，去创建一个
N. Pavlidis | H. Gogas | R. Wirtz | G. Aravantinos | G. Fountzilas | R. Kronenwett | D. Pectasides | D. Bafaloukos | K. Kalogeras | A. Eleftheraki | T. Makatsoris | N. Nikitas | E. Timotheadou | V. Kotoula | C. Christodoulou | D. Televantou | E. Razis